AQR Arbitrage’s Global Blood Therapeutics, Inc. GBT Stock Holding History

AQR Arbitrage’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-605,777	Closed	-$41.3M	–	1559
2022 Q3	$41.3M	Buy	+605,777	New	+$33.4M	0.91%	11
2022 Q1	–	Sell	-83,123	Closed	-$2.43M	–	1564
2021 Q4	$2.43M	Buy	+83,123	New	+$2.57M	0.06%	344

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's GBT Position: Q4 2022 in Review

AQR Arbitrage sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 605,777 shares — an estimated $41.3M sold.

AQR Arbitrage first reported a position in GBT in Q4 2021 and held it in 2 quarters. The position peaked at $41.3M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

AQR Arbitrage reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 605,777 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $41.3M.
AQR Arbitrage first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 2 quarters.
AQR Arbitrage's Global Blood Therapeutics, Inc. position peaked at $41.3M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.